bioRxivCancer Biology
Variable Number Tandem Repeats (VNTRs) as modifiers of breast cancer risk in carriers of BRCA1 185delAG
Y. C. Ding, A. W. Adamson, M. Bakhtiari, C. Patrick, J. Park, Y. Laitman, J. N. Weitzel, V. Bafna, E. Friedman, S. L. Neuhausen
Abstract
Despite substantial efforts in identifying both rare and common variants affecting disease risk, in the majority of diseases, a large proportion of unexplained genetic risk remains. We propose that variable number tandem repeats (VNTRs) may explain a proportion of the missing genetic risk. Herein, we tested whether VNTRs are causal modifiers of breast cancer risk in 347 female carriers of BRCA1 185delAG, an important group given their high risk of developing breast cancer. We performed targeted-capture to sequence VNTRs, called genotypes with adVNTR, and tested the association of VNTRs and breast cancer risk using Cox regression models. Of 303 VNTRs that passed quality control checks, 4 VNTRs were significantly associated with risk to develop breast cancer at false discovery rate [FDR] < 0.05 and an additional 4 VNTRs had FDR < 0.25. After determining the specific risk alleles, there was a significantly earlier age at development of breast cancer in carriers of the risk genotypes compared to those without the risk genotypes for seven of eight VNTRs. Results from this first systematic study of VNTRs demonstrate that VNTRs may explain a proportion of the unexplained genetic risk for disease and have larger effects than SNPs.
- organism: human
- assay: DNA methylation
- research focus: variant effect prediction
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rare copy number variants (CNVs) and breast cancer risk
Joe Dennis, Jonathan P. Tyrer, … Rita Katharina Schmutzler·bioRxiv·May 20, 2021
- Association of Gene Variant Type and Location with Breast Cancer Risk in the General Population
Mwangala P. Akamandisa, Nicholas James Boddicker, … Katherine L. Nathanson·Annals of OncologyPeer-reviewed·Apr 25, 2025
- Segregation analysis of 17,425 population-based breast cancer families: evidence for genetic susceptibility and risk prediction
Shuai Li, Robert J. MacInnis, … Antonis C. Antoniou·The American Journal of Human GeneticsPeer-reviewed·Oct 1, 2022
- Prevalence and spectrum of germline BRCA1 and BRCA2 mutations in multiethnic cohort of breast cancer patients in Brunei Darussalam
Siti Nur Idayu Matusin, Nuramalina H Mumin, … Mas Rina Wati Haji Abdul Hamid·PLoS ONEPeer-reviewed·Jun 18, 2025
- Genetic assessments of breast cancer risk that do not account for polygenic background are incomplete and lead to incorrect preventative strategies
George Busby, Paul Craig, … Giordano Bottà·medRxiv·Aug 13, 2021
- Assessing the variations in breast/ovarian cancer risk for Chinese BRCA1/2 carriers
Ang Li, Yi Zi, … Yujian Shi·Journal of OncologyPeer-reviewed·Mar 26, 2022